Nektar Therapeutics (NKTR)
43.33
+1.05
(+2.48%)
USD |
NASDAQ |
Jan 02, 13:44
Nektar Therapeutics Research and Development Expense (TTM): 116.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 695.91M |
| Lyell Immunopharma, Inc. | 140.98M |
| Owlet, Inc. | 12.94M |
| Amgen, Inc. | 6.828B |
| Rigel Pharmaceuticals, Inc. | 28.24M |